HCA Holdings Inc Stock News

HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Vertex Pharmaceuticals is an innovative biotech with a robust portfolio and rich pipeline. HCA Healthcare leads an area of the healthcare industry that isn't easy to break into now.

HCA Healthcare's shares have risen 8% from last year but fallen 15% from their summer high. The company's earnings have undershot expectations due to slower margin recovery and a joint venture mishap.

Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.

HCA Healthcare Inc. HCA, -0.67% said Thursday it's targeting per-share earnings growth of 8% to 12% for the next five years. The hospital operator offered the forecast in a statement released ahead of

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: November 14, 2023 at 11:45am EST at the 2023 Wolfe Healthcare Confer

The U.S. economy added 150,000 jobs in October 2023, below market forecasts of 180,000.

HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HCA Healthcare, Inc. (NYSE:HCA ) Q3 2023 Earnings Conference Call October 24, 2023 10:00 AM ET Company Participants Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Frank

HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70

HCA beat on revenue but missed earnings estimates with its third-quarter report. Management credited strong demand for its top-line performance but noted its Valesco physician staffing joint venture p

HCA Healthcare (HCA) came out with quarterly earnings of $3.91 per share, missing the Zacks Consensus Estimate of $3.97 per share. This compares to earnings of $3.93 per share a year ago.

Shares of HCA Healthcare HCA, -0.08% fell 9% premarket Tuesday, after the hospital operator reported third quarter profit that missed analysts' expectations. Net income was $1.079 billion, or $3.91 pe

HCA Healthcare missed Wall Street estimates for quarterly profit on Tuesday, hurt by an increase in staffing costs as the company was impacted by its physician staffing joint venture Valesco.

HCA Healthcare (HCA) closed the most recent trading day at $244.05, moving +0.64% from the previous trading session.